Cannabidiol as a Potential Treatment for Anxiety and Mood Disorders: Molecular Targets and Epigenetic Insights from Preclinical Research

Cannabidiol (CBD) is the most abundant non-psychoactive component of cannabis; it displays a very low affinity for cannabinoid receptors, facilitates endocannabinoid signaling by inhibiting the hydrolysis of anandamide, and stimulates both transient receptor potential vanilloid 1 and 2 and serotonin...

Descripción completa

Detalles Bibliográficos
Autores principales: Melas, Philippe A., Scherma, Maria, Fratta, Walter, Cifani, Carlo, Fadda, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917759/
https://www.ncbi.nlm.nih.gov/pubmed/33668469
http://dx.doi.org/10.3390/ijms22041863

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917759/
https://www.ncbi.nlm.nih.gov/pubmed/33668469
http://dx.doi.org/10.3390/ijms22041863

Ejemplares similares